Corporate information

Official name
Aposense Limited
Registration country

Company type

A clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology.

Funding rounds

N/A


( )

Profile Country Notes
Ziegler Meditech Equity Partners LP USD 3,000,000 (USD 3,000,000)


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials